Alternative Interventions to Prevent Oxidative Damage following Ischemia/Reperfusion
暂无分享,去创建一个
Araceli Castillo-Romero | E. Cardona-Muñoz | S. Totsuka-Sutto | T. García-Cobián | E. J. Ramírez-Lizardo | S. Q. Rodríguez-Lara | Leonel García-Benavides
[1] Warszawski Uniwersytet Medyczny,et al. Diabetes care , 2019, Health at a Glance.
[2] S. Kapadia,et al. Ischemic postconditioning during primary percutaneous coronary intervention , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[3] ヒロシ クスノキ. Telmisartan Exerts Renoprotective Actions via Peroxisome Proliferator-Activated Receptor-γ/Hepatocyte Growth Factor Pathway Independent of Angiotensin II Type 1 Receptor Blockade , 2017 .
[4] Carol Coupland,et al. Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care , 2016, British Medical Journal.
[5] J. Scholey,et al. Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion. , 2016, American journal of physiology. Cell physiology.
[6] I. Spasojević,et al. Mitochondria-Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion Injury , 2016, Oxidative medicine and cellular longevity.
[7] L. Yao,et al. Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Ameliorates Chronic Kidney Disease by Enhancing Antioxidative Capacity and Attenuating Angiogenesis in the Kidney of a 5/6 Nephrectomized Rat Model , 2016, Cellular Physiology and Biochemistry.
[8] H. S. Hundal,et al. Modulation of cellular redox homeostasis by the endocannabinoid system , 2016, Open Biology.
[9] S. Raina,et al. Pioglitazone-induced congestive heart failure and pulmonary edema in a patient with preserved ejection fraction , 2016, Journal of pharmacology & pharmacotherapeutics.
[10] P. Kovacic,et al. Natural Monophenols as Therapeutics, Antioxidants and Toxins; Electron Transfer, Radicals and Oxidative Stress , 2015 .
[11] Ž. Župan,et al. A single dose of PPARγ agonist pioglitazone reduces cortical oxidative damage and microglial reaction following lateral fluid percussion brain injury in rats , 2015, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[12] Sang-Man Jin,et al. Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database , 2015, Diabetes & metabolism journal.
[13] Kade Birkeland,et al. Managing Comorbidities in Patients with Chronic Heart Failure: First, Do No Harm , 2015, American Journal of Cardiovascular Drugs.
[14] C. Morgan,et al. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users , 2015, European Neuropsychopharmacology.
[15] V. Di Marzo,et al. Are cannabidiol and Δ9‐tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review , 2015, British journal of pharmacology.
[16] A. Guo,et al. Intensive Atorvastatin Therapy Attenuates the Inflammatory Responses in Monocytes of Patients with Unstable Angina Undergoing Percutaneous Coronary Intervention via Peroxisome Proliferator-Activated Receptor γ Activation , 2015, Inflammation.
[17] Silvio E. Inzucchi,et al. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. , 2014, JAMA.
[18] N. Sattar,et al. A dysglycaemic effect of statins in diabetes: relevance to clinical practice? , 2014, Diabetologia.
[19] C. Currie,et al. Combination therapy with metformin plus sulphonylureas versus metformin plus DPP‐4 inhibitors: association with major adverse cardiovascular events and all‐cause mortality , 2014, Diabetes, obesity & metabolism.
[20] P. Ferdinandy,et al. Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning , 2014, Pharmacological Reviews.
[21] M. Pfeffer,et al. Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored. , 2014, The lancet. Diabetes & endocrinology.
[22] M. Pollak,et al. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria , 2014, The Biochemical journal.
[23] G. Umpierrez,et al. Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3) , 2014, Diabetes Care.
[24] Nora D Volkow,et al. Adverse health effects of marijuana use. , 2014, The New England journal of medicine.
[25] R. Korthuis,et al. Mitochondrial reactive oxygen species: A double edged sword in ischemia/reperfusion vs preconditioning , 2014, Redox biology.
[26] Benjamin J. Whalley,et al. Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders , 2014, Epilepsia.
[27] Andrea Glasauer,et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis , 2014, eLife.
[28] P. Kovacic,et al. Cannabinoids (CBD, CBDHQ and THC): Metabolism, Physiological Effects, Electron Transfer, Reactive Oxygen Species and Medical Use , 2014 .
[29] E. Caglayan,et al. Remote ischemic preconditioning and renoprotection: from myth to a novel therapeutic option? , 2014, Journal of the American Society of Nephrology : JASN.
[30] M. Barančík,et al. Effects of PPARγ Agonist Pioglitazone on Redox-Sensitive Cellular Signaling in Young Spontaneously Hypertensive Rats , 2013, PPAR research.
[31] T. Münzel,et al. Oxidative Stress and Vascular Function , 2013 .
[32] D. Goulis,et al. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review. , 2013, Metabolism: clinical and experimental.
[33] Sang-Wook Kim,et al. Ischemic Postconditioning During Primary Percutaneous Coronary Intervention: The Effects of Postconditioning on Myocardial Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction (POST) Randomized Trial , 2013, Circulation.
[34] L. Bu,et al. Ischemic Postconditioning-Mediated miRNA-21 Protects against Cardiac ischemia/reperfusion Injury via PTEN/Akt Pathway , 2013, PloS one.
[35] A. D. da Silva,et al. Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants , 2013, Molecules.
[36] Zimin Shi,et al. Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacity. , 2013, The Journal of surgical research.
[37] Francisco Garrido-Latorre,et al. La carga de enfermedad, lesiones, factores de riesgo y desafíos para el sistema de salud en México , 2013 .
[38] W. Zin,et al. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury. , 2013, International immunopharmacology.
[39] S. Miescher,et al. C1 Esterase Inhibitor Reduces Lower Extremity Ischemia/Reperfusion Injury and Associated Lung Damage , 2013, PloS one.
[40] Steven P Jones,et al. Historical perspective on the pathology of myocardial ischemia/reperfusion injury. , 2013, Circulation research.
[41] P. Hurn,et al. Biological Sex and Mechanisms of Ischemic Brain Injury , 2013, Translational Stroke Research.
[42] J. Ijzermans,et al. Protection Against Renal Ischemia-Reperfusion Injury by Ischemic Postconditioning , 2013, Transplantation.
[43] T. Kurtz,et al. Telmisartan modulates mitochondrial function in vascular smooth muscle cells , 2013, Hypertension Research.
[44] L. Mascitelli,et al. Do Statins Cause Diabetes? , 2013, Current Diabetes Reports.
[45] T. Joh,et al. Telmisartan Inhibits Cell Proliferation by Blocking Nuclear Translocation of ProHB-EGF C-Terminal Fragment in Colon Cancer Cells , 2013, PloS one.
[46] B. Kalyanaraman. Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms☆ , 2013, Redox biology.
[47] Johnny C. Hong,et al. Ischaemia–reperfusion injury in liver transplantation—from bench to bedside , 2013, Nature Reviews Gastroenterology &Hepatology.
[48] N. Gonzalez,et al. Clinical Application of Preconditioning and Postconditioning to Achieve Neuroprotection , 2013, Translational Stroke Research.
[49] J. Berger,et al. Statins and Diabetes: The Good, the Bad, and the Unknown , 2013, Current Atherosclerosis Reports.
[50] D. Yellon,et al. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. , 2013, The Journal of clinical investigation.
[51] Michael Rocco. Statins and diabetes risk: Fact, fiction, and clinical implications , 2012, Cleveland Clinic Journal of Medicine.
[52] Yanjie Lu,et al. miR-1 Exacerbates Cardiac Ischemia-Reperfusion Injury in Mouse Models , 2012, PloS one.
[53] A. Thotakura,et al. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. , 2012, Trends in cell biology.
[54] P. McGuire,et al. A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation. , 2012, Current pharmaceutical design.
[55] A. Tomassetti,et al. Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer , 2012, Oncogene.
[56] X. Zhang,et al. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK) , 2012, Oncogene.
[57] P. Kranke,et al. Remote Ischemic Conditioning to Protect against Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis , 2012, PloS one.
[58] F. Dequiedt,et al. Phosphorylation of p65(RelA) on Ser547 by ATM Represses NF-κB-Dependent Transcription of Specific Genes after Genotoxic Stress , 2012, PloS one.
[59] J. Saavedra,et al. Telmisartan directly ameliorates the neuronal inflammatory response to IL-1β partly through the JNK/c-Jun and NADPH oxidase pathways , 2012, Journal of Neuroinflammation.
[60] L. Pfeffer,et al. DNA Damage Induces NF-κB-dependent MicroRNA-21 Up-regulation and Promotes Breast Cancer Cell Invasion* , 2012, The Journal of Biological Chemistry.
[61] Hanrui Zhang,et al. Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: mechanisms and therapeutic implications. , 2012, Journal of molecular and cellular cardiology.
[62] Zhijian Yang,et al. Improvement of Arterial Stiffness by Reducing Oxidative Stress Damage in Elderly Hypertensive Patients After 6 Months of Atorvastatin Therapy , 2012, Journal of clinical hypertension.
[63] B. Schroen,et al. Small but smart--microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing. , 2012, Cardiovascular research.
[64] C. Franceschi,et al. Charting the NF-κB Pathway Interactome Map , 2012, PloS one.
[65] B. Viollet,et al. Cellular and molecular mechanisms of metformin: an overview. , 2012, Clinical science.
[66] Correction for Delhase et al., TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2 , 2012, Proceedings of the National Academy of Sciences.
[67] B. Göttgens,et al. The Transcription Factor Erg Controls Endothelial Cell Quiescence by Repressing Activity of Nuclear Factor (NF)-κB p65* , 2012, The Journal of Biological Chemistry.
[68] C. Piccinato,et al. The protective effect of cilostazol on isolated rabbit femoral arteries under conditions of ischemia and reperfusion: the role of the nitric oxide pathway , 2012, Clinics.
[69] Y. Taniyama,et al. Telmisartan Exerts Renoprotective Actions via Peroxisome Proliferator-activated Receptor-␥/hepatocyte Growth Factor Pathway Independent of Angiotensin Ii Type 1 Receptor Blockade Materials and Methods Experimental Uuo Model in at 1a R-deficient Mice , 2022 .
[70] J. Joven,et al. PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways , 2012, PPAR research.
[71] D. Mozaffarian,et al. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.
[72] Omer Kalayci,et al. Oxidative Stress and Antioxidant Defense , 2012, The World Allergy Organization journal.
[73] J. Saavedra,et al. Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-&ggr; activation in human monocytes , 2012, Journal of hypertension.
[74] M. Karin,et al. TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2 , 2011, Proceedings of the National Academy of Sciences.
[75] Yuichiro Yamada,et al. Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy , 2011, Hypertension Research.
[76] G. Heusch,et al. Mitochondrial STAT3 Activation and Cardioprotection by Ischemic Postconditioning in Pigs With Regional Myocardial Ischemia/Reperfusion , 2011, Circulation research.
[77] Yuichiro Yamada,et al. Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2Akita diabetic mice , 2011, Hypertension Research.
[78] T. Eckle,et al. Ischemia and reperfusion—from mechanism to translation , 2011, Nature Medicine.
[79] A. Barzegar,et al. Intracellular ROS Protection Efficiency and Free Radical-Scavenging Activity of Curcumin , 2011, PloS one.
[80] Y. Okita,et al. Antioxidant properties of pioglitazone limit nicotinamide adenine dinucleotide phosphate hydrogen oxidase and augment superoxide dismutase activity in cardiac allotransplantation. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[81] U. Kintscher,et al. High-Dose Treatment With Telmisartan Induces Monocytic Peroxisome Proliferator-Activated Receptor-&ggr; Target Genes in Patients With the Metabolic Syndrome , 2011, Hypertension.
[82] T. Münzel,et al. Nitroglycerin-Induced Endothelial Dysfunction and Tolerance Involve Adverse Phosphorylation and S-Glutathionylation of Endothelial Nitric Oxide Synthase: Beneficial Effects of Therapy With the AT1 Receptor Blocker Telmisartan , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[83] David L. Williams,et al. Toll-like receptors: new players in myocardial ischemia/reperfusion injury. , 2011, Antioxidants & redox signaling.
[84] Y. Zhai,et al. Liver Ischemia and Reperfusion Injury: New Insights into Mechanisms of Innate—Adaptive Immune‐Mediated Tissue Inflammation , 2011, American Journal of Transplantation.
[85] J. Bauersachs,et al. Biogenesis and Regulation of Cardiovascular MicroRNAs , 2011, Circulation Research.
[86] B. Nehru,et al. Curcumin Attenuates Aluminum-Induced Oxidative Stress and Mitochondrial Dysfunction in Rat Brain , 2011, Neurotoxicity Research.
[87] Yong Li,et al. MicroRNAs in NF-kappaB signaling. , 2011, Journal of molecular cell biology.
[88] G. Mantovani,et al. Long-term protective effects of the angiotensin receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress and myocardial dysfunction. , 2011, Experimental and therapeutic medicine.
[89] D. Wink,et al. Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death , 2011, Free radical biology & medicine.
[90] Jinqiao Qian,et al. The role of microRNA in modulating myocardial ischemia-reperfusion injury. , 2011, Physiological genomics.
[91] M. Brand,et al. Assessing mitochondrial dysfunction in cells , 2011, The Biochemical journal.
[92] M. Isobe,et al. Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma , 2011, Laboratory Investigation.
[93] D. Butterfield,et al. Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action. , 2011, Pharmacological research.
[94] N. Hariharan,et al. Is Autophagy in Response to Ischemia and Reperfusion Protective or Detrimental for the Heart? , 2011, Pediatric Cardiology.
[95] N. Palanisamy,et al. Activation of NF-{kappa}B by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4. , 2011, Cancer research.
[96] K. Priyadarsini,et al. Reactions of reactive oxygen species (ROS) with curcumin analogues: Structure–activity relationship , 2011, Free radical research.
[97] Yan Zhou,et al. The Codon 72 Polymorphism of p53 Regulates Interaction with NF-κB and Transactivation of Genes Involved in Immunity and Inflammation , 2011, Molecular and Cellular Biology.
[98] R. Muelleman,et al. Tourniquet-induced acute ischemia-reperfusion injury in mouse skeletal muscles: Involvement of superoxide. , 2011, European journal of pharmacology.
[99] A. Veves,et al. Cannabidiol Attenuates Cardiac Dysfunction , Oxidative Stress , Fibrosis , and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy , 2017 .
[100] E. Chiquete,et al. Manejo agudo y pronóstico a un año en pacientes mexicanos con un primer infarto cerebral: resultados del estudio multicéntrico PREMIER , 2010 .
[101] Julián Alcalá Ramírez,et al. Enfermedad isquémica del corazón, epidemiología y prevención , 2010 .
[102] S. Bilgiç,et al. Effect of preconditioned hyperbaric oxygen and ozone on ischemia-reperfusion induced tourniquet in skeletal bone of rats. , 2010, The Journal of surgical research.
[103] P. Neufer,et al. Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats. , 2010, Free radical biology & medicine.
[104] Yan-Yan Zhang,et al. MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. , 2010 .
[105] M. Valko,et al. Metals, oxidative stress and neurodegenerative disorders , 2010, Molecular and Cellular Biochemistry.
[106] RyosukeTakahashi,et al. Nonhypotensive Dose of Telmisartan Attenuates Cognitive Impairment Partially Due to Peroxisome Proliferator-Activated Receptor-γ Activation in Mice With Chronic Cerebral Hypoperfusion , 2010 .
[107] Joseph A. Hill,et al. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. , 2010, The American journal of cardiology.
[108] J. Iacomini,et al. Identification of a microRNA signature of renal ischemia reperfusion injury , 2010, Proceedings of the National Academy of Sciences.
[109] Dachun Yang,et al. Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway , 2010, Journal of cellular and molecular medicine.
[110] M. Okusa,et al. Macrophages, dendritic cells, and kidney ischemia-reperfusion injury. , 2010, Seminars in nephrology.
[111] J. Liao,et al. Pleiotropic effects of statins. - Basic research and clinical perspectives -. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[112] Wei Du,et al. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: Down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability , 2010, Brain Research.
[113] H. Cao,et al. Comparison of Effects of Simvastatin Versus Atorvastatin on Oxidative Stress in Patients With Coronary Heart Disease , 2010, Clinical cardiology.
[114] Dachun Yang,et al. Telmisartan Prevents Weight Gain and Obesity Through Activation of Peroxisome Proliferator-Activated Receptor-&dgr;-Dependent Pathways , 2010, Hypertension.
[115] A. Oral,et al. Atorvastatin reduces tissue damage in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation , 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.
[116] Samir Ghosh,et al. Efficient and improved synthesis of Telmisartan , 2010, Beilstein journal of organic chemistry.
[117] Suyun Huang,et al. Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma. , 2010, Oncology reports.
[118] P. Storz,et al. Reactive oxygen species in cancer , 2010, Free radical research.
[119] Kevin Struhl,et al. An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.
[120] A. Redington,et al. Translation of remote ischaemic preconditioning into clinical practice , 2009, The Lancet.
[121] S. Ghosh,et al. The NF-kappaB family of transcription factors and its regulation. , 2009, Cold Spring Harbor perspectives in biology.
[122] D. Lefer,et al. Protective ischaemia in patients: preconditioning and postconditioning. , 2009, Cardiovascular research.
[123] Chie Aoki,et al. Telmisartan inhibits cytokine-induced nuclear factor-κB activation independently of the peroxisome proliferator-activated receptor-γ , 2009, Hypertension Research.
[124] Heng Zhao. Ischemic Postconditioning as a Novel Avenue to Protect against Brain Injury after Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[125] J. Huffmyer,et al. Physiology and Pharmacology of Myocardial Preconditioning and Postconditioning , 2009, Seminars in cardiothoracic and vascular anesthesia.
[126] K. Umezawa,et al. Chemosensitization and immunosensitization of resistant cancer cells to apoptosis and inhibition of metastasis by the specific NF-kappaB inhibitor DHMEQ. , 2009, Current pharmaceutical design.
[127] E. Sontheimer,et al. Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.
[128] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[129] M. Halici,et al. Protective effects of telmisartan on ischemia/reperfusion injury of rat ovary: biochemical and histopathologic evaluation. , 2008, Fertility and sterility.
[130] B. Aggarwal,et al. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. , 2008, Cancer letters.
[131] D. Yellon,et al. Remote ischaemic preconditioning: underlying mechanisms and clinical application. , 2008, Cardiovascular research.
[132] Peng Huang,et al. Redox regulation of cell survival. , 2008, Antioxidants & redox signaling.
[133] J. Bian,et al. Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning. , 2008, American journal of physiology. Heart and circulatory physiology.
[134] R. Pedrinelli,et al. Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells. , 2008, Atherosclerosis.
[135] Ling Zhao,et al. The Phosphatidylinositol 3‐Kinase/Akt Pathway Negatively Regulates Nod2‐Mediated NF‐kappaB Pathway , 2008, Biochemical pharmacology.
[136] C. Charriaut-Marlangue,et al. Gender-Related Differences in Apoptotic Pathways After Neonatal Cerebral Ischemia , 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[137] S. Geuna,et al. The paradigm of postconditioning to protect the heart , 2007, Journal of cellular and molecular medicine.
[138] P. Ferdinandy,et al. Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning , 2007, Pharmacological Reviews.
[139] C. Lotan,et al. Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury. , 2007, American Journal of Physiology. Heart and Circulatory Physiology.
[140] G. Dobson,et al. Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury. , 2007, Journal of applied physiology.
[141] T. Cole,et al. Transient Limb Ischemia Induces Remote Preconditioning and Remote Postconditioning in Humans by a KATP Channel–Dependent Mechanism , 2007, Circulation.
[142] E. Murphy,et al. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. , 2007, Cardiovascular research.
[143] M. Dal‐Pai‐Silva,et al. Ischaemia and reperfusion effects on skeletal muscle tissue: morphological and histochemical studies , 2007, International journal of experimental pathology.
[144] M. Simoons,et al. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies. , 2007, Cardiovascular research.
[145] Kun Hao,et al. Pharmacokinetic-pharmacodynamic modeling of telmisartan using an indirect response model in spontaneously hypertensive rats , 2007, Acta Pharmacologica Sinica.
[146] M. Duchen,et al. Endothelial Mitochondria: Contributing to Vascular Function and Disease , 2007, Circulation research.
[147] J. Li,et al. Oxidative Stress and Neurodegenerative Disorders , 2007, International journal of molecular sciences.
[148] A. Galinier,et al. Physiological diversity of mitochondrial oxidative phosphorylation. , 2006, American journal of physiology. Cell physiology.
[149] T. Pedrazzini,et al. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway. , 2006, Cardiovascular research.
[150] K. Sunagawa,et al. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma. , 2006, Cardiovascular research.
[151] Dean P. Jones. Redefining oxidative stress. , 2006, Antioxidants & redox signaling.
[152] D. Baltimore,et al. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.
[153] S. Akira,et al. TLR8-mediated NF-κB and JNK Activation Are TAK1-independent and MEKK3-dependent* , 2006, Journal of Biological Chemistry.
[154] L. Argaud,et al. Mitochondrial permeability transition pore and postconditioning. , 2006, Cardiovascular research.
[155] D. Yellon,et al. Survival kinases in ischemic preconditioning and postconditioning. , 2006, Cardiovascular research.
[156] J. Vinten-johansen,et al. Postconditioning: reduction of reperfusion-induced injury. , 2006, Cardiovascular research.
[157] Z. Yu,et al. Deregulated GSK3β activity in colorectal cancer: its association with tumor cell survival and proliferation , 2006 .
[158] D. Yellon,et al. Postconditioning Protects Against Endothelial Ischemia-Reperfusion Injury in the Human Forearm , 2006, Circulation.
[159] M. Lesser. Oxidative stress in marine environments: biochemistry and physiological ecology. , 2006, Annual review of physiology.
[160] W. Schlack,et al. The Influence of Mitochondrial KATP-Channels in the Cardioprotection of Preconditioning and Postconditioning by Sevoflurane in the Rat In Vivo , 2005, Anesthesia and analgesia.
[161] G. Finet,et al. Postconditioning the Human Heart , 2005, Circulation.
[162] K. Meldrum,et al. Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injury. , 2005, Cardiovascular research.
[163] Nicholas M. Caruso,et al. Susceptibility of the heart to ischaemia–reperfusion injury and exercise‐induced cardioprotection are sex‐dependent in the rat , 2005, The Journal of physiology.
[164] R. Urrutia,et al. Glycogen Synthase Kinase-3β Participates in Nuclear Factor κB–Mediated Gene Transcription and Cell Survival in Pancreatic Cancer Cells , 2005 .
[165] P. Cohen,et al. Glycogen Synthase from Rabbit Skeletal Muscle , 2005 .
[166] K. Korach,et al. Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. , 2005, Journal of molecular and cellular cardiology.
[167] A. A. Starkov,et al. Mitochondrial metabolism of reactive oxygen species , 2005, Biochemistry (Moscow).
[168] L. Argaud,et al. Postconditioning Inhibits Mitochondrial Permeability Transition , 2005, Circulation.
[169] M. Peters,et al. KATP Channel Activation Induces Ischemic Preconditioning of the Endothelium in Humans In Vivo , 2004, Circulation.
[170] H. Drexler,et al. Regulation of Proangiogenic Factor CCN1 in Cardiac Muscle: Impact of Ischemia, Pressure Overload, and Neurohumoral Activation , 2004, Circulation.
[171] R. Guyton,et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. , 2004, Cardiovascular research.
[172] Francesca Zazzeroni,et al. Gadd45β mediates the NF-κB suppression of JNK signalling by targeting MKK7/JNKK2 , 2004, Nature Cell Biology.
[173] Giulio Superti-Furga,et al. A physical and functional map of the human TNF-α/NF-κB signal transduction pathway , 2004, Nature Cell Biology.
[174] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[175] C. Foyer,et al. Redox sensing and signalling associated with reactive oxygen in chloroplasts, peroxisomes and mitochondria , 2003 .
[176] R. Guyton,et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. , 2003, American journal of physiology. Heart and circulatory physiology.
[177] Sujay K. Singh,et al. Hydrogen Peroxide Activates NF-κB through Tyrosine Phosphorylation of IκBα and Serine Phosphorylation of p65 , 2003, Journal of Biological Chemistry.
[178] Yung-Hyun Choi,et al. Phosphorylation of NF-kappa B by calmodulin-dependent kinase IV activates anti-apoptotic gene expression. , 2003, Biochemical and biophysical research communications.
[179] N. Mackman,et al. The Phosphatidylinositol 3-Kinase-Akt Pathway Limits Lipopolysaccharide Activation of Signaling Pathways and Expression of Inflammatory Mediators in Human Monocytic Cells* , 2002, The Journal of Biological Chemistry.
[180] C. Hunter,et al. NF-κB Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions , 2002, Clinical Microbiology Reviews.
[181] David A. Brenner,et al. Role of glycogen synthase kinase-3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes , 2002 .
[182] J. Jordán,et al. Nitric Oxide and Superoxide, a Deadly Cocktail , 2002, Annals of the New York Academy of Sciences.
[183] Francesca Zazzeroni,et al. Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling , 2001, Nature.
[184] R. Ratan,et al. The Epidermal Growth Factor Receptor Engages Receptor Interacting Protein and Nuclear Factor-κB (NF-κB)-inducing Kinase to Activate NF-κB , 2001, The Journal of Biological Chemistry.
[185] P. Godowski,et al. Toll-like receptor 2–mediated NF-κB activation requires a Rac1-dependent pathway , 2000, Nature Immunology.
[186] S. Westerheide,et al. Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II* , 2000, The Journal of Biological Chemistry.
[187] J. Kehrer. The Haber-Weiss reaction and mechanisms of toxicity. , 2000, Toxicology.
[188] Quan Zhao,et al. Mitogen-activated Protein Kinase/ERK Kinase Kinases 2 and 3 Activate Nuclear Factor-κB through IκB Kinase-α and IκB Kinase-β* , 1999, The Journal of Biological Chemistry.
[189] J. Ninomiya-Tsuji,et al. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway , 1999, Nature.
[190] Kristina Riehemann,et al. Regulation of NF-κB Activation by MAP Kinase Cascades , 1997 .
[191] Y. Park,et al. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, enhances LPS-induced NO production from murine peritoneal macrophages. , 1997, Biochemical and biophysical research communications.
[192] D. Wallach,et al. MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1 , 1997, Nature.
[193] R. Jennings,et al. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.
[194] G. Schmid-Schönbein,et al. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. , 1983, The American journal of pathology.
[195] G. Tamma,et al. Oxidative Medicine and Cellular Longevity , 2018 .
[196] M. Koike,et al. Effects of ischemic preconditioning and cilostazol on muscle ischemia-reperfusion injury in rats. , 2014, Acta cirurgica brasileira.
[197] M. Hernán,et al. An analysis of electronic medical records to evaluate possible bias due to differential survival , 2013 .
[198] C. Baines,et al. Cell biology of ischemia/reperfusion injury. , 2012, International review of cell and molecular biology.
[199] Yumin Chen,et al. Telmisartan counteracts TGF-β1 induced epithelial-to-mesenchymal transition via PPAR-γ in human proximal tubule epithelial cells. , 2012, International journal of clinical and experimental pathology.
[200] M. N. Saldivar,et al. Enfermedad vascular cerebral: incidencia y factores de riesgo en el Hospital General La Perla , 2012 .
[201] P. Pinton,et al. Relation between mitochondrial membrane potential and ROS formation. , 2012, Methods in molecular biology.
[202] Michael J Morgan,et al. Crosstalk of reactive oxygen species and NF-κB signaling , 2011, Cell Research.
[203] Yanrui Li,et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1 , 2011, Nature Medicine.
[204] Wei Z. Wang. Investigation of reperfusion injury and ischemic preconditioning in microsurgery , 2009, Microsurgery.
[205] N. Perkins,et al. Integrating cell-signalling pathways with NF-κB and IKK function , 2007, Nature Reviews Molecular Cell Biology.
[206] N. Kay,et al. Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells. , 2007, Blood.
[207] G. Gross,et al. Reperfusion injury: does it exist? , 2007, Journal of molecular and cellular cardiology.
[208] 今山 郁代. Telmisartan downregulates angiotensin 2 type 1 receptor through activation of peroxisome proliferator-activated receptor γ , 2007 .
[209] C. Sen,et al. Mitochondrial nitric oxide synthase. , 2007, Frontiers in bioscience : a journal and virtual library.
[210] B. Su,et al. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3 , 2004, Nature Immunology.
[211] S. Westerheide,et al. Tumor Necrosis Factor a -induced Phosphorylation of RelA/p65 on Ser 529 Is Controlled by Casein Kinase II* , 2000 .
[212] P. Cohen,et al. Glycogen synthase from rabbit skeletal muscle. Amino acid sequence at the sites phosphorylated by glycogen synthase kinase-3, and extension of the N-terminal sequence containing the site phosphorylated by phosphorylase kinase. , 1980, European journal of biochemistry.